INCY vs IQV
Incyte Corp. and Iqvia Holdings Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | INCY | IQV |
|---|---|---|
| Revenue | $5.1B | $16.3B |
| Net income | $1.3B | $1.4B |
| Gross margin | 92.8% | 33.3% |
| Net margin | 25.0% | 8.3% |
| Return on equity | 29.9% | 21.6% |
| Diluted EPS | $6.41 | $7.84 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | · | $2.1B |
| Equity | $5.2B | $6.5B |
| Net debt / equity | · | 2.11× |
| Current ratio | 3.32× | 0.75× |
| Revenue CAGR 5y | 14.0% | 7.5% |
| Profit CAGR 5y | · | 37.3% |
IQV bills 3.2× the revenue of INCY, and INCY keeps more of each dollar of revenue as profit (25.0% against 8.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | INCY | IQV |
|---|---|---|
| FY2025 | $5.1B | $16.3B |
| FY2024 | $4.2B | $15.4B |
| FY2023 | $3.7B | $15.0B |
| FY2022 | $3.4B | $14.4B |
| FY2021 | $3.0B | $13.9B |
| FY2020 | $2.7B | $11.4B |
| FY2019 | $2.2B | $11.1B |
| FY2018 | $1.9B | $10.4B |
| FY2017 | $1.5B | $9.7B |
| FY2016 | $1.1B | $6.8B |
Bottom line
| Fiscal year | INCY | IQV |
|---|---|---|
| FY2025 | $1.3B | $1.4B |
| FY2024 | $32.6M | $1.4B |
| FY2023 | $597.6M | $1.4B |
| FY2022 | $340.7M | $1.1B |
| FY2021 | $948.6M | $966.0M |
| FY2020 | $-295.7M | $279.0M |
| FY2019 | $446.9M | $191.0M |
| FY2018 | $109.5M | $259.0M |
| FY2017 | $-313.1M | $1.3B |
| FY2016 | $104.2M | $72.0M |
15 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$11,168,758,000 | IQV |
| FY2024 | −$11,163,783,000 | IQV |
| FY2023 | −$11,288,351,000 | IQV |
| FY2022 | −$11,015,365,000 | IQV |
| FY2021 | −$10,887,733,000 | IQV |
| FY2020 | −$8,692,298,000 | IQV |
| FY2019 | −$8,929,241,000 | IQV |
| FY2018 | −$8,530,117,000 | IQV |
| FY2017 | −$8,165,784,000 | IQV |
| FY2016 | −$5,709,281,000 | IQV |
| FY2015 | −$4,983,249,000 | IQV |
| FY2014 | −$4,948,505,000 | IQV |
| FY2013 | −$4,744,598,000 | IQV |
| FY2012 | −$4,568,454,000 | IQV |
| FY2011 | −$4,233,293,000 | IQV |
IQV has reported the higher revenue in every one of these 15 fiscal years. The gap has widened since the earliest year compared.
15 of 17 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +16.7 pp | INCY |
| FY2024 | −8.1 pp | IQV |
| FY2023 | +7.1 pp | INCY |
| FY2022 | +2.5 pp | INCY |
| FY2021 | +24.8 pp | INCY |
| FY2020 | −13.8 pp | IQV |
| FY2019 | +18.7 pp | INCY |
| FY2018 | +3.1 pp | INCY |
| FY2017 | −33.7 pp | IQV |
| FY2016 | +8.1 pp | INCY |
The higher net margin has changed hands between INCY and IQV over this period.
10 of 15 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
INCY's net margin has been more volatile than IQV's over the 10 comparable fiscal years — 15.2 percentage points of standard deviation against 3.7.
10 of 15 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between INCY and IQV over these 10 fiscal years — INCY led in 7 and IQV in 3.
10 of 15 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
INCY's return on equity has been more volatile than IQV's over the 9 comparable fiscal years — 18.3 percentage points of standard deviation against 7.8.
9 of 10 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between INCY and IQV over these 9 fiscal years — INCY led in 4 and IQV in 5.
9 of 10 comparable fiscal years — a year missing data on either side is not counted.